{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:45:31Z","timestamp":1782139531908,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The definition of the gene expression profile of genes encoding Ion Channels and Transporters (ICT-GEP) represents a novel and attracting aspect in cancer. We determined the ICT-GEP of Follicular Lymphoma (FL), and compared it with that of the more aggressive Diffuse Large B Cell Lymphoma (DLBCL). cDNA microarray data were collected both from patients enrolled for this study, and from public datasets. In FL the ICT-GEP indicated the overexpression of both the K<jats:sup>+<\/jats:sup> channel encoding gene <jats:italic>KCNN4<\/jats:italic>, and <jats:italic>SLC2A1<\/jats:italic>, which encodes the Glut1 glucose transporter. <jats:italic>SLC2A1<\/jats:italic> turned out to represent the hub of a functional network, connecting channels and transporters in FL. Relapsed FL patients were characterised by 38 differentially expressed ICT genes, among which <jats:italic>ATP9A<\/jats:italic>, <jats:italic>SLC2A1<\/jats:italic> and <jats:italic>KCNN4<\/jats:italic> were under-expressed, indicating a down-regulation of both excitability and glycolysis. A completely different profile of K<jats:sup>+<\/jats:sup> channel encoding genes emerged in DLBCL accompanied by the over-expression of the fatty acid transporter-encoding gene <jats:italic>SLC27A1<\/jats:italic> as well as of the metabolism regulator <jats:italic>NCoR1<\/jats:italic>. This indicates a change in excitability and a shift towards an oxidative metabolism in DLBCL. Overall, the ICT-GEP may contribute to identifying novel lymphoma biomarkers related to excitability and metabolic pathways, with particular relevance for drug resistant, relapsed FL.<\/jats:p>","DOI":"10.1038\/s41598-019-44661-x","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T10:02:28Z","timestamp":1560420148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Alberto","family":"Magi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Masselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Laise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Rigacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Breschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Crociani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pillozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-9648","authenticated-orcid":false,"given":"Annarosa","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"44661_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-70","volume":"2","author":"S Novelli","year":"2013","unstructured":"Novelli, S., Briones, J. & Sierra, J. Epidemiology of lymphoid malignancies, last decade update. Springerplus 2, 70 (2013).","journal-title":"Springerplus"},{"key":"44661_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton, L. M. et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood 107, 265\u2013276 (2006).","journal-title":"Blood"},{"key":"44661_CR3","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","volume":"23","author":"WT Swenson","year":"2005","unstructured":"Swenson, W. T. et al. Improved survival of follicular lymphoma patients in the United States. J. Clin. Oncol. 23, 5019\u20135026 (2005).","journal-title":"J. Clin. Oncol."},{"key":"44661_CR4","doi-asserted-by":"publisher","first-page":"12747","DOI":"10.1073\/pnas.1002057107","volume":"107","author":"JM Irish","year":"2010","unstructured":"Irish, J. M. et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc. Natl. Acad. Sci. USA 107, 12747\u201312754 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"44661_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","volume":"1","author":"B Acker","year":"1983","unstructured":"Acker, B. et al. Histologic conversion in the non-Hodgkin\u2019s lymphomas. J. Clin. Oncol. 1, 11\u20136 (1983).","journal-title":"J. Clin. Oncol."},{"key":"44661_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","volume":"311","author":"SJ Horning","year":"1984","unstructured":"Horning, S. J. & Rosenberg, S. A. The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas. N. Engl. J. Med. 311, 1471\u20135 (1984).","journal-title":"N. Engl. J. Med."},{"key":"44661_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511 (2000).","journal-title":"Nature"},{"key":"44661_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 3, 185\u2013197 (2003).","journal-title":"Cancer Cell."},{"key":"44661_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","volume":"105","author":"AM Glas","year":"2005","unstructured":"Glas, A. M. et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 105, 301\u2013307 (2005).","journal-title":"Blood"},{"key":"44661_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","volume":"25","author":"AM Glas","year":"2007","unstructured":"Glas, A. M. et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J. Clin. Oncol. 25, 390\u2013398 (2007).","journal-title":"J. Clin. Oncol."},{"key":"44661_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gcc.20617","volume":"48","author":"C Schwaenen","year":"2009","unstructured":"Schwaenen, C. et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Canc. 48, 39\u201354 (2009).","journal-title":"Genes Chromosomes Canc."},{"key":"44661_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood.V99.1.282","volume":"99","author":"H Husson","year":"2002","unstructured":"Husson, H. et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 99, 282\u2013289 (2002).","journal-title":"Blood"},{"key":"44661_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11899-008-0026-6","volume":"3","author":"A Martinez","year":"2008","unstructured":"Martinez, A., Carreras, J. & Campo, E. The follicular lymphoma microenvironment, From tumor cell to host immunity. Curr. Hematol. Malig. Rep. 3, 179\u2013186 (2008).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"44661_CR14","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel, R., Sehn, L. H. & Gascoyne, R. D. Pathogenesis of follicular lymphoma. J. Clin. Invest. 122, 3424\u20133431 (2012).","journal-title":"J. Clin. Invest."},{"issue":"10 Pt B","key":"44661_CR15","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.bbamem.2014.12.016","volume":"1848","author":"E Lastraioli","year":"2015","unstructured":"Lastraioli, E., Iorio, J. & Arcangeli, A. Ion channel expression as promising cancer biomarker. Biochim. Biophys. Acta. 1848(10 Pt B), 2685\u2013702 (2015).","journal-title":"Biochim. Biophys. Acta."},{"key":"44661_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-106","volume":"12","author":"JH Ko","year":"2013","unstructured":"Ko, J. H. et al. Expression profiling of ion channel genes predicts clinical outcome in breast cancer. Mol. Cancer. 12, 106 (2013).","journal-title":"Mol. Cancer."},{"issue":"1","key":"44661_CR17","doi-asserted-by":"publisher","first-page":"e86569","DOI":"10.1371\/journal.pone.0086569","volume":"9","author":"JH Ko","year":"2014","unstructured":"Ko, J. H. et al. Ion channel gene expression in lung adenocarcinoma, potential role in prognosis and diagnosis. PLoS One 9(1), e86569 (2014).","journal-title":"PLoS One"},{"key":"44661_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep11593","volume":"5","author":"R Wang","year":"2015","unstructured":"Wang, R. et al. Ion channel gene expression predicts survival in glioma patients. Sci. Rep. 5, 11593 (2015).","journal-title":"Sci. Rep."},{"key":"44661_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","volume":"33","author":"S Feske","year":"2015","unstructured":"Feske, S., Wulff, H. & Skolnik, E. Y. Ion Channels in Innate and Adaptive Immunity. Annu. Rev. Immunol. 33, 291\u2013353 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"44661_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2174\/092986712798992093","volume":"19","author":"A Arcangeli","year":"2012","unstructured":"Arcangeli, A., Pillozzi, S. & Becchetti, A. Targeting ion channels in leukemias, a new challenge for treatment. Curr. Med. Chem. 19, 683\u2013696 (2012).","journal-title":"Curr. Med. Chem."},{"key":"44661_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2006.00267.x","volume":"97","author":"M Suguro","year":"2006","unstructured":"Suguro, M. et al. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup, development of a CD5 signature. Cancer Sci. 97, 868\u2013874 (2006).","journal-title":"Cancer Sci."},{"key":"44661_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1365-2141.2008.07125.x","volume":"141","author":"IM Overes","year":"2008","unstructured":"Overes, I. M. et al. Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis. Br. J. Haematol. 141, 799\u2013807 (2008).","journal-title":"Br. J. Haematol."},{"key":"44661_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13277-009-0005-0","volume":"31","author":"A Birerdinc","year":"2010","unstructured":"Birerdinc, A. et al. Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region. Tumour Biol. 31, 33\u201345 (2010).","journal-title":"Tumour Biol."},{"key":"44661_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.6093263","volume":"226","author":"Y Tsujimoto","year":"1984","unstructured":"Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C. & Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(1418) chromosome translocation. Science. 226, 1097\u20139 (1984).","journal-title":"Science."},{"key":"44661_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2012.00053","volume":"2","author":"M Masselli","year":"2012","unstructured":"Masselli, M. et al. Deregulation of ion channel and transporter encoding genes in pediatric gliomas. Front. Oncol. 2, 53 (2012).","journal-title":"Front. Oncol."},{"key":"44661_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11248-012-9667-2","volume":"22","author":"S Gatti","year":"2013","unstructured":"Gatti, S. et al. Gene expression profiling of HGF\/Met activation in neonatal mouse heart. Transgenic Res. 22, 579\u2013593 (2013).","journal-title":"Transgenic Res."},{"key":"44661_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno, M. et al. Mutations of multiple genes cause deregulation of NF-kB in diffuse large B-cell lymphoma. Nature 459, 717\u201321 (2009).","journal-title":"Nature"},{"key":"44661_CR28","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/sj.leu.2402572","volume":"16","author":"S Pillozzi","year":"2002","unstructured":"Pillozzi, S. et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 16, 1791\u20131798 (2002).","journal-title":"Leukemia"},{"key":"44661_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1085\/jgp.89.2.185","volume":"89","author":"S Grinstein","year":"1987","unstructured":"Grinstein, S. & Cohen, S. Role of Membrane Potential and Volume-activated Na+\/H+ Exchange. J Gen Physiol. 89, 185\u2013213 (1987).","journal-title":"J Gen Physiol."},{"key":"44661_CR30","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","volume":"71","author":"TG Sommermann","year":"2011","unstructured":"Sommermann, T. G., O\u2019Neill, K., Plas, D. R. & Cahir-McFarland, E. IKKbeta and NF-kappaB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res. 71, 7291\u20137300 (2011).","journal-title":"Cancer Res."},{"key":"44661_CR31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ncb2324","volume":"13","author":"C Mauro","year":"2011","unstructured":"Mauro, C. et al. NF-\u03baB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nature Cell Biology. 13, 1272\u20131279 (2011).","journal-title":"Nature Cell Biology."},{"key":"44661_CR32","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1074\/jbc.M801954200","volume":"283","author":"L Samavati","year":"2008","unstructured":"Samavati, L., Lee, I., Mathes, I., Lottspeich, F. & H\u00fcttemann, M. Tumor Necrosis Factor \u03b1 Inhibits Oxidative Phosphorylation through Tyrosine Phosphorylation at Subunit I of Cytochrome c Oxidase. JBC. 283, 21134\u201321144 (2008).","journal-title":"JBC."},{"key":"44661_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.60","volume":"4","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y., Butler, E. B. & Tan, M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 4, e532 (2013).","journal-title":"Cell Death Dis"},{"key":"44661_CR34","doi-asserted-by":"publisher","first-page":"30773","DOI":"10.1074\/jbc.M104133200","volume":"276","author":"ZG Wang","year":"2001","unstructured":"Wang, Z. G., White, S. P. & Ackerman, S. H. Atp11p and Atp12p Are Assembly Factors for the F1-ATPase in Human Mitochondria. The Journal of Biological Chemistry 276, 30773\u201330778 (2001).","journal-title":"The Journal of Biological Chemistry"},{"key":"44661_CR35","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1091\/mbc.E16-08-0586","volume":"27","author":"Y Tanaka","year":"2016","unstructured":"Tanaka, Y. et al. The phospholipid flippase ATP9A is required for the recycling pathway from the endosomes to the plasma membrane. Mol Biol Cell. 27, 3883\u20133893 (2016).","journal-title":"Mol Biol Cell."},{"key":"44661_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep18669","volume":"6","author":"A Nath","year":"2016","unstructured":"Nath, A. & Chan, C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Scientific Reports. 6, 18669 (2016).","journal-title":"Scientific Reports."},{"key":"44661_CR37","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.celrep.2016.05.052","volume":"15","author":"P Navarro","year":"2016","unstructured":"Navarro, P. et al. Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics. Cell Reports 15, 2705\u201318 (2016).","journal-title":"Cell Reports"},{"key":"44661_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/cbin.10973","volume":"42","author":"TI Lima","year":"2018","unstructured":"Lima, T. I. et al. Role of NCoR1 in mitochondrial function and energy metabolism. Cell Biology International. 42, 734\u2013741 (2018).","journal-title":"Cell Biology International."},{"key":"44661_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P. et al. Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B-Cell Lymphoma. Cancer Cell. 22, 547\u2013560 (2012).","journal-title":"Cancer Cell."},{"key":"44661_CR40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/1873-3468.12087","volume":"590","author":"L Maneix","year":"2016","unstructured":"Maneix, L. & Catic, A. Touch and go, nuclear proteolysis in the regulation of metabolic genes and cancer. FEBS Lett. 590, 908\u2013923 (2016).","journal-title":"FEBS Lett."},{"key":"44661_CR41","unstructured":"Swerdlow, S. H. et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, (4th edn., volume 2). (IARC Publications, 2008)."},{"key":"44661_CR42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland, K. R., Armitage, J. O. & Hancock, B. W. Non-Hodgkin lymphoma. Lancet. 380, 848\u2013857 (2012).","journal-title":"Lancet."},{"key":"44661_CR43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1182\/blood-2006-02-003772","volume":"110","author":"S Pillozzi","year":"2007","unstructured":"Pillozzi, S. et al. EGFR-1 (FLT-1), \u03b21 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia, role in cell migration and clinical outcome. Blood. 110, 1238\u20131250 (2007).","journal-title":"Blood."},{"key":"44661_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/106652701300099074","volume":"8","author":"MA Newton","year":"2001","unstructured":"Newton, M. A., Kendziorski, C. M., Richmond, C. S., Blattner, F. R. & Tsui, K. W. On differential variability of expression ratios, improving statistical inference about gene expression changes from microarray data. J Comput Biol. 8, 37\u201352 (2001).","journal-title":"J Comput Biol."},{"key":"44661_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal, an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u20134 (2012).","journal-title":"Cancer Discov."},{"key":"44661_CR46","first-page":"11","volume":"2","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2, 11 (2013).","journal-title":"Sci Signal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44661-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:33:11Z","timestamp":1671273191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44661-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44661"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44661-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"30 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8586"}}